Victory Capital Management Inc. Boosts Position in The Cooper Companies, Inc. (NASDAQ:COO)

Victory Capital Management Inc. grew its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 23.0% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 3,950,119 shares of the medical device company's stock after buying an additional 737,726 shares during the quarter. Victory Capital Management Inc. owned 1.98% of Cooper Companies worth $435,856,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently made changes to their positions in the stock. Ashton Thomas Securities LLC bought a new stake in Cooper Companies in the 3rd quarter worth $25,000. Covestor Ltd boosted its stake in shares of Cooper Companies by 305.9% during the 1st quarter. Covestor Ltd now owns 276 shares of the medical device company's stock valued at $28,000 after purchasing an additional 208 shares in the last quarter. Innealta Capital LLC bought a new stake in shares of Cooper Companies during the 2nd quarter valued at about $25,000. Crewe Advisors LLC boosted its stake in shares of Cooper Companies by 286.4% during the 2nd quarter. Crewe Advisors LLC now owns 340 shares of the medical device company's stock valued at $30,000 after purchasing an additional 252 shares in the last quarter. Finally, Clearstead Trust LLC bought a new stake in Cooper Companies during the first quarter worth about $36,000. Hedge funds and other institutional investors own 24.39% of the company's stock.

Analysts Set New Price Targets

COO has been the topic of several research reports. Robert W. Baird boosted their price objective on shares of Cooper Companies from $118.00 to $125.00 and gave the stock an "outperform" rating in a research note on Thursday, August 29th. Stifel Nicolaus reissued a "buy" rating and set a $115.00 price objective (up previously from $110.00) on shares of Cooper Companies in a research note on Thursday, August 29th. Jefferies Financial Group raised shares of Cooper Companies from a "hold" rating to a "buy" rating and lifted their target price for the stock from $107.00 to $115.00 in a report on Tuesday, July 16th. StockNews.com raised shares of Cooper Companies from a "hold" rating to a "buy" rating in a report on Friday. Finally, Morgan Stanley lifted their target price on shares of Cooper Companies from $95.00 to $104.00 and gave the stock an "equal weight" rating in a report on Tuesday, September 10th. Three equities research analysts have rated the stock with a hold rating and ten have given a buy rating to the company. According to data from MarketBeat.com, Cooper Companies currently has an average rating of "Moderate Buy" and a consensus price target of $117.00.

Insider Activity at Cooper Companies

In other news, COO Daniel G. Mcbride sold 114,992 shares of the stock in a transaction on Wednesday, September 4th. The shares were sold at an average price of $105.48, for a total value of $12,129,356.16. Following the sale, the chief operating officer now owns 44,696 shares of the company's stock, valued at approximately $4,714,534.08. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In related news, CAO Agostino Ricupati sold 1,601 shares of the firm's stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $108.03, for a total value of $172,956.03. Following the transaction, the chief accounting officer now owns 4,818 shares of the company's stock, valued at $520,488.54. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, COO Daniel G. Mcbride sold 114,992 shares of the firm's stock in a transaction dated Wednesday, September 4th. The stock was sold at an average price of $105.48, for a total transaction of $12,129,356.16. Following the completion of the transaction, the chief operating officer now directly owns 44,696 shares in the company, valued at $4,714,534.08. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 256,373 shares of company stock valued at $27,637,427 over the last 90 days. 2.00% of the stock is owned by corporate insiders.

Cooper Companies Price Performance

Shares of NASDAQ:COO traded down $1.55 during midday trading on Tuesday, reaching $102.00. 1,798,381 shares of the company were exchanged, compared to its average volume of 1,121,790. The company has a current ratio of 1.99, a quick ratio of 1.18 and a debt-to-equity ratio of 0.33. The business's fifty day moving average is $107.26 and its two-hundred day moving average is $97.73. The Cooper Companies, Inc. has a one year low of $81.99 and a one year high of $112.38. The stock has a market cap of $20.31 billion, a PE ratio of 57.69, a price-to-earnings-growth ratio of 2.24 and a beta of 0.99.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its earnings results on Wednesday, August 28th. The medical device company reported $0.96 earnings per share for the quarter, topping analysts' consensus estimates of $0.91 by $0.05. The firm had revenue of $1 billion during the quarter, compared to analyst estimates of $997.30 million. Cooper Companies had a net margin of 9.45% and a return on equity of 9.08%. Cooper Companies's revenue for the quarter was up 7.8% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.84 earnings per share. As a group, analysts predict that The Cooper Companies, Inc. will post 3.65 earnings per share for the current year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.